 SOUTH SAN FRANCISCO, Calif., Aug. 02, 2022 GLOBE NEWSWIRE -- Harpoon Therapeutics, Inc. NASDAQ: HARP, a clinical-stage immunotherapy company developing novel T cell engagers, today announced that management will participate in two upcoming investor conferences: 